The DRG Rubella Virus IgM Enzyme Immunoassay Kit provides materials for the quantitative and qualitative determination of IgM-class antibodies to Rubella Virus in human serum and plasma. This product is for Research Use Only; International customers contact your representative to receive information about the CE marked version.
The DRG Rubella Virus IgM ELISA is a solid phase enzyme-linked immunosorbent assay (ELISA). Patient samples are diluted with Sample Diluent and additionally incubated with IgG-RF-Sorbent, to eliminate competitive inhibition from specific IgG and to remove rheumatoid factors. This pretreatment avoids false negative or false positive results.
Microtiter wells as a solid phase are coated with inactivated K1S grade Rubella Virus antigen (strain HPV-77). Diluted patient specimens and ready-for-use controls are pipetted into these wells. During incubation Rubella Virus-specific antibodies of positive specimens and controls are bound to the immobilized antigens. After a washing step to remove unbound sample and control material horseradish peroxidase conjugated anti-human IgM antibodies are dispensed into the wells. During a second incubation this anti-IgM conjugate binds specifically to IgM antibodies resulting in the formation of enzyme-linked immune complexes. After a second washing step to remove unbound conjugate the immune complexes formed (in case of positive results) are detected by incubation with TMB substrate and development of a blue color. The blue color turns into yellow by stopping the enzymatic indicator reaction with sulfuric acid. The intensity of this color is directly proportional to the amount of Rubella Virus-specific IgM antibody in the patient specimen. Absorbance at 450 nm is read using an ELISA microtiter plate reader.